Patents by Inventor Christoph Kahl

Christoph Kahl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11063533
    Abstract: The present invention relates to a control circuit (10) for controlling a resonant power converter. It is described to generate (210) a modulation signal. A carrier signal is generates (220), wherein the generation of the carrier signal comprises measuring at least one signal from the power converter. A switching signal is generated (230) that is useable to control a value of at least one magnitude of the resonant power converter based on the modulation signal and the carrier signal.
    Type: Grant
    Filed: June 12, 2018
    Date of Patent: July 13, 2021
    Assignee: KONINKLIJKE PHILIPS N.V.
    Inventors: Albert Garcia I Tormo, Oliver Woywode, Christoph Kahl, Bernhard Wagner
  • Publication number: 20210152102
    Abstract: The present invention relates to a control circuit (10) for controlling a resonant power converter. It is described to generate (210) a modulation signal. A carrier signal is generates (220), wherein the generation of the carrier signal comprises measuring at least one signal from the power converter. A switching signal is generated (230) that is useable to control a value of at least one magnitude of the resonant power converter based on the modulation signal and the carrier signal.
    Type: Application
    Filed: June 12, 2018
    Publication date: May 20, 2021
    Inventors: ALBERT GARCIA I TORMO, OLIVER WOYWODE, CHRISTOPH KAHL, BERNHARD WAGNER
  • Patent number: 9586998
    Abstract: The invention provides methods for propagating a monkey adenovirus in a cell, including a human cell, comprising one or more gene products isolated from a human adenovirus. Also provided are methods for propagating wherein the monkey adenovirus comprises a nucleic acid sequence encoding a human adenovirus gene product. The invention further provides a monkey adenovirus, including a replication-deficient monkey adenovirus, obtained by such propagation methods.
    Type: Grant
    Filed: August 4, 2015
    Date of Patent: March 7, 2017
    Assignee: GenVec, Inc.
    Inventors: Jason Gall, Douglas Brough, Christoph Kahl, Duncan McVey
  • Publication number: 20150329834
    Abstract: The invention provides methods for propagating a monkey adenovirus in a cell, including a human cell, comprising one or more gene products isolated from a human adenovirus. Also provided are methods for propagating wherein the monkey adenovirus comprises a nucleic acid sequence encoding a human adenovirus gene product. The invention further provides a monkey adenovirus, including a replication-deficient monkey adenovirus, obtained by such propagation methods.
    Type: Application
    Filed: August 4, 2015
    Publication date: November 19, 2015
    Applicant: GenVec, Inc.
    Inventors: Jason Gall, Douglas Brough, Christoph Kahl, Duncan McVey
  • Patent number: 9133248
    Abstract: The invention provides methods for propagating a monkey adenovirus in a cell including a human cell, comprising one or more gene products isolated from a human adenovirus. Also provided are methods for propagating wherein the monkey adenovirus comprises a nucleic acid sequence encoding a human adenovirus gene product. The invention further provides a monkey adenovirus. including a replication-deficient monkey adenovirus, obtained by such propagation methods.
    Type: Grant
    Filed: November 9, 2010
    Date of Patent: September 15, 2015
    Assignee: GenVec, Inc.
    Inventors: Jason Gall, Douglas Brough, Christoph Kahl, Duncan McVey
  • Publication number: 20120225470
    Abstract: The invention provides methods for propagating a monkey adenovirus in a cell including a human cell, comprising one or more gene products isolated from a human adenovirus. Also provided are methods for propagating wherein the monkey adenovirus comprises a nucleic acid sequence encoding a human adenovirus gene product. The invention further provides a monkey adenovirus. including a replication-deficient monkey adenovirus, obtained by such propagation methods.
    Type: Application
    Filed: November 9, 2010
    Publication date: September 6, 2012
    Applicant: Genvec, Inc.
    Inventors: Jason Gall, Douglas Brough, Christoph Kahl, Duncan McVey
  • Publication number: 20110123569
    Abstract: The invention is directed to a live attenuated serotype 14 adenovirus, and a method of inducing an immune response against a serotype 14 adenovirus in a mammal using the live attenuated serotype 14 adenovirus.
    Type: Application
    Filed: December 11, 2008
    Publication date: May 26, 2011
    Applicants: GenVec, Inc., The Government of the United States of America, as represented by the Secretary
    Inventors: Jason G.D. Gall, Christoph Kahl, Gary J. Nabel